Impact of Coronary Microvascular Dysfunction on Left Ventricular Function After Percutaneous Coronary Intervention: Assessment With Combined Dipyridamole-Exercise Stress and Myocardial Strain/Work

Echocardiography. 2026 Mar;43(3):e70419. doi: 10.1111/echo.70419.ABSTRACTBACKGROUND: Coronary microvascular dysfunction (CMD) persists after percutaneous coronary intervention (PCI) in individuals with coronary artery disease (CAD). This study assessed CMD using combined dipyridamole-exercise stress

W Wanyu Zhao

Primary Cardiac Lymphomas: Diagnosis and Management

JACC Case Rep. 2026 Mar 17:107366. doi: 10.1016/j.jaccas.2026.107366. Online ahead of print.ABSTRACTPrimary cardiac lymphomas (PCLs) are rare and often present a diagnostic challenge because of nonspecific clinical and imaging findings. Delayed diagnosis may lead to rapid clinical deterioration. We

A Alexandra Pons-Riverola

Early intervention for high-risk smoldering multiple myeloma (SMM)

Cochrane Database Syst Rev. 2026 Mar 18;3:CD015494. doi: 10.1002/14651858.CD015494.pub2.ABSTRACTRATIONALE: Smoldering multiple myeloma (SMM) represents an intermediate stage between monoclonal gammopathy of undetermined significance (MGUS) and active multiple myeloma. Early identification and interv

P Po-Huang Chen

Predicting heart failure decompensation: focus on non-invasive monitoring

Cardiol J. 2026;33:e00226028. doi: 10.5603/cj.107197.ABSTRACTPolandAbstractHeart failure (HF) remains the foremost global health problem. Decompensation of chronic HF, char-acterized by exacerbation of symptoms and signs of congestion, reduces functional capacity and quality of life, and increases t

M Maja Kłopecka